Effects of droxidopa when measuring gait speed, kyphosis, and functional reach in Parkinson’s disease
Objective: To determine if droxidopa improves gait speed, kyphosis, and functional reach in Parkinson’s disease when added to routine care treatment. Background: Fall risk factors…Bipolar directional DBS in VIM-stimulated patients
Objective: To compare circular, directional and bipolar stimulation in VIM-implanted PD- and ET-patients regarding effect and side-effect thresholds in a cross-sectional design. Background: So far,…Improvements of tremor control and life quality of refractory essential tremor patients after MR-guided focused ultrasound thalamotomy – A Taiwan experience
Objective: To quantify the tremor control and life quality changes of refractory essential tremor (ET) patients after the MR-guided focused ultrasound (MRgFUS) thalamotomy in Taiwan.…INTREPID: A Prospective, Double Blinded, Multicenter Randomized Controlled Trial Evaluating Deep Brain Stimulation with a New Multiple Source, Constant Current Rechargeable System in Parkinson’s disease
Objective: INTREPID is designed to assess the improvement in motor function and quality of life in patients with Parkinson’s disease (PD) following Deep Brain Stimulation…Specific active immunotherapy (SAIT) against alpha-synuclein with AFFITOPE® PD01A and PD03A: Results from the AFF009 phase I trial
Objective: Phase I study with AFFITOPE® PD01A and PD03A to assess safety and tolerability as well as immunogenicity of this approach in MSA patients. Background:…PASSPORT, An Ongoing Phase 2 Study in Patients with PSP– Baseline Characteristics
Objective: To describe baseline characteristics of the participants with progressive supranuclear palsy (PSP) enrolled in the ongoing PASSPORT (NCT03068468) phase 2 study. Background: PSP is…A German-Austrian multicenter, non-interventional, prospective study for the treatment with abobotulinumtoxinA injections in naïve and previously treated patients suffering from cervical dystonia
Objective: In this prospective, multicenter, non-interventional study (NCT01840462) the primary objective was effectiveness of abobotulinumtoxinA in BoNT treatment-naïve and previously treated subjects after two injection…Background: Transcranial magnetic stimulation (rTMS) may influence the progression of PD
Objective: We hypothesized that the regularly repeated rTMS would decrease the development of PD and that there might be a synergistic effect with transcranial direct…Effect of PD medication on disease progression as measured by rate of change in MDS_UPDRS and DaT SBR in PPMI study
Objective: In clinical trials for new PD therapies, it is common for patients to start to take approved symptomatic PD medications during the study. The…Low-Fat Versus Ketogenic Diet In Parkinson’s Disease: A Pilot Randomized Controlled Trial
Objective: To compare the plausibility, safety, and efficacy of a low-fat, high-carbohydrate diet versus a ketogenic diet in a hospital clinic of PD patients. Background:…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.